Prime Therapeutics receives prestigious Silver Anvil Award from Public Relations Society of America
ST. PAUL, Minn., June 17, 2013 /PRNewswire/ -- Prime Therapeutics, in collaboration with public relations agency, Weber Shandwick, and branding and design agency, Larsen, was awarded the Silver Anvil for its internal communication campaign "Millions of Reasons, One Purpose, Repositioning Prime Therapeutics." The award was presented at the Public Relations Society of America (PRSA) 2013 Silver Anvil Awards Ceremony held June 13 at the AXA Equitable Center in New York.
The Silver Anvil, which has been presented annually since 1946, is the oldest and one of the most prestigious awards competitions for outstanding achievement in public relations, based on its rigorous judging criteria and emphasis on measurement and evaluation.
"This Silver Anvil award recognizes work we undertook to simplify and redefine our purpose statement to clearly reflect the important work we do to help people get the medicine they need to feel better and live well," said Michael Showalter, chief marketing officer at Prime. "Our employees have embraced this new purpose statement because it focuses on the people we truly serve."
PRSA, which is based in New York, is the largest professional organization serving the U.S. public relations community. With a mission to "advance the profession and the professional," PRSA provides news and information, thought leadership, continuing education and networking opportunities. It also sets standards of professional excellence and advocates for the business value of public relations.
About Prime Therapeutics
Prime Therapeutics LLC (Prime) helps people get the medicine they need to feel better and live well. Prime manages pharmacy benefits for health plans, employers, and government programs including Medicare and Medicaid. The company processes claims and delivers medicine to members, offering clinical services for people with complex medical conditions. Headquartered in St. Paul, Minn., Prime serves nearly 20 million people. It is collectively owned by 13 Blue Cross and Blue Shield Plans, subsidiaries or affiliates of those plans. Prime has been recognized as one of the fastest-growing private companies in the nation.
For more information, visit www.primetherapeutics.com or follow @Prime_PBM on Twitter.
SOURCE Prime Therapeutics